Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PACB

Pacific Biosciences of California Inc

May 08 • 04:00PM ET

1.41

-0.24 -14.55 %

Healthcare • Medical Devices • USA • Small • NASD

Today, 9:52 AMPacBio posts Q1 2026 EPS -$0.03 on flat $37.2M revenue, trims 2026 outlook as instruments lag consumables

Peers: TXG ILMN BNGO TWST QGEN

| Held by: ARKK ARKG VTI IWM VXF IWN IBB SCHA PRFZ VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.43	Insider Own	9.59%	Shs Outstand	302.00M	Perf Week	-11.88%
Market Cap	425.82M	Forward P/E	-	EPS next Y	-0.47	Insider Trans	-2.75%	Shs Float	273.04M	Perf Month	4.44%
Enterprise Value	853.25M	PEG	-	EPS next Q	-0.13	Inst Own	59.69%	Short Float	16.98%	Perf Quarter	-22.53%
Income	-128.58M	P/S	2.66	EPS this Y	73.99%	Inst Trans	4.18%	Short Ratio	7.69	Perf Half Y	-26.37%
Sales	160.03M	P/B	79.62	EPS next Y	0.46%	ROA	-15.65%	Short Interest	46.36M	Perf YTD	-24.60%
Book/sh	0.02	P/C	1.54	EPS next 5Y	38.91%	ROE	-273.55%	52W High	2.73 -48.35%	Perf Year	17.50%
Cash/sh	0.91	P/FCF	-	EPS past 3/5Y	-9.18% -	ROIC	-18.22%	52W Low	0.85 65.67%	Perf 3Y	-88.49%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.64% 15.19%	Gross Margin	47.30%	Volatility	8.19% 7.56%	Perf 5Y	-94.34%
Dividend TTM	-	EV/Sales	5.33	EPS Y/Y TTM	81.29%	Oper. Margin	-88.30%	ATR (14)	0.13	Perf 10Y	-83.79%
Dividend Ex-Date	-	Quick Ratio	6.70	Sales Y/Y TTM	5.04%	Profit Margin	-80.34%	RSI (14)	42.15	Recom	2.25
Dividend Gr. 3/5Y	- -	Current Ratio	7.78	EPS Q/Q	98.11%	SMA20	-11.82%	Beta	2.40	Target Price	2.38
Payout	-	Debt/Eq	296.79	Sales Q/Q	0.07%	SMA50	-4.52%	Rel Volume	1.62	Prev Close	1.65
Employees	485	LT Debt/Eq	296.79	Earnings	May 07 AMC	SMA200	-16.26%	Avg Volume	6.03M	Price	1.41
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	78.83% -6.92%	Trades		Volume	9,783,926	Change	-14.55%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-06-26	Downgrade	Barclays	Equal Weight → Underweight	$1.50
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20

Show Previous Ratings

Today 08:30AM	Pacific Biosciences of California, Inc. Q1 2026 Earnings Call Summary (Moby) -14.55%
May-07-26 04:33PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press)
04:05PM	PacBio Announces First Quarter 2026 Financial Results (GlobeNewswire)
Apr-21-26 09:05AM	PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing (GlobeNewswire)
Apr-16-26 04:05PM	PacBio to Report First Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
09:05AM	Loading…
Apr-15-26 09:05AM	PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples (GlobeNewswire)
Mar-18-26 09:05AM	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative (GlobeNewswire)
Mar-06-26 02:00PM	PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know (StockStory) -9.21%
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
Mar-05-26 10:57AM	Clover Health Enters Collaboration to Be Part of CMS Aligned Network (Zacks)
10:56AM	Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now (Zacks)
08:30AM	PacBio Announces the Appointment of Chris Gibson to the Board of Directors (GlobeNewswire)
Mar-04-26 09:20AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:52AM	Intuitive Surgical Expands Direct Operational Presence in Europe (Zacks)
Mar-03-26 10:33PM	Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) (StockStory) -6.17%
10:15AM	Loading…
10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Feb-27-26 04:15PM	PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know (StockStory) -5.62%
Feb-25-26 11:50AM	TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates (Zacks)
Feb-24-26 03:10PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +5.06%
09:05AM	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research (GlobeNewswire)
Feb-20-26 10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
Feb-19-26 11:01PM	PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
12:35AM	5 Must-Read Analyst Questions From PacBio's Q4 Earnings Call (StockStory)
Feb-18-26 04:05PM	PacBio to Participate in the TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-13-26 10:24AM	PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up (Zacks) -7.07%
08:30AM	Pacific Biosciences of California, Inc. Q4 2025 Earnings Call Summary (Moby)
08:21AM	PACB Q4 Deep Dive: Consumables and Clinical Adoption Drive Growth as SparkNex Launch Nears (StockStory)
12:03AM	Pacific Biosciences of California Inc (PACB) Q4 2025 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Feb-12-26 08:14PM	Pacific Biosciences of California Q4 Earnings Call Highlights (MarketBeat)
05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:56PM	Loading…
04:56PM	PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025 (StockStory)
04:40PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner (GlobeNewswire)
Feb-10-26 10:04PM	PacBio Earnings: What To Look For From PACB (StockStory)
Feb-02-26 09:05AM	PacBio Completes Sale of Short-Read Sequencing Assets (GlobeNewswire) -8.85%
Jan-30-26 06:15PM	Here's Why Pacific Biosciences of California (PACB) Fell More Than Broader Market (Zacks)
Jan-27-26 04:05PM	PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 (GlobeNewswire) -7.39%
Jan-23-26 06:15PM	Pacific Biosciences of California (PACB) Stock Dips While Market Gains: Key Facts (Zacks)
Jan-16-26 06:15PM	Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know (Zacks) -5.96% +6.79%
Jan-15-26 10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
Jan-12-26 09:15AM	PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases (GlobeNewswire)
09:05AM	PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC) (GlobeNewswire)
09:05AM	PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire)
Jan-09-26 11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
Jan-08-26 11:01PM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
09:05AM	PacBio and UC Davis Researchers Introduce CiFi, a New Long-Read 3C Method That Enables Chromosome-Scale Assemblies from a Single SMRT Cell (GlobeNewswire)
Jan-07-26 06:15PM	Pacific Biosciences of California (PACB) Gains As Market Dips: What You Should Know (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
Jan-06-26 07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks) +5.05%
Jan-05-26 12:23PM	ARK Invest Boosts Gene-Editing Bets While Cutting Consumer Tech Exposure (GuruFocus.com) +7.61%
Jan-02-26 11:01AM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
08:00AM	Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 (StockStory)
Dec-31-25 05:00PM	Why Is PacBio (PACB) Stock Soaring Today (StockStory) +8.09%
06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:49PM	Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) (Insider Monkey)
04:05PM	PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-03-25 03:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
Nov-28-25 09:05AM	PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 09:40AM	Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? (Zacks) -9.13%
Nov-24-25 01:00PM	PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know (StockStory) +12.61%
Nov-18-25 08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks) +5.10%
Nov-13-25 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.32%
12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks)
Nov-12-25 03:20PM	Why PacBio (PACB) Shares Are Getting Obliterated Today (StockStory) -6.45%
12:36AM	5 Revealing Analyst Questions From PacBio's Q3 Earnings Call (StockStory)
Nov-11-25 12:26PM	Why PacBio (PACB) Stock Is Up Today (StockStory) +5.68%
Nov-10-25 10:35PM	Spotting Winners: PacBio (NASDAQ:PACB) And Life Sciences Tools & Services Stocks In Q3 (StockStory)
Nov-06-25 01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) -7.05%
12:33AM	PACB Q3 Deep Dive: Consumable Strength Offsets Instrument Headwinds, Clinical Expansion in Focus (StockStory)
Nov-05-25 06:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:54PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:10PM	PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q3 Earnings (StockStory)
04:02PM	PacBio Announces Third Quarter 2025 Financial Results (GlobeNewswire)
09:05AM	HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes (GlobeNewswire)
Nov-04-25 09:15AM	Pacific Biosciences (PACB) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks) -10.71%
09:05AM	PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China (GlobeNewswire)
Nov-03-25 10:07PM	PacBio Earnings: What To Look For From PACB (StockStory)
Oct-31-25 02:11PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +20.62%
Oct-28-25 06:15PM	Pacific Biosciences of California (PACB) Stock Drops Despite Market Gains: Important Facts to Note (Zacks) -5.74%
Oct-24-25 02:36PM	PacBio (PACB) Stock Is Up, What You Need To Know (StockStory)
Oct-22-25 04:05PM	PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire) +5.98%
Oct-21-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -4.04%: What You Should Know (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks) +20.73%
Oct-14-25 06:15PM	Pacific Biosciences of California (PACB) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks) +9.43%
06:05AM	PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities (GlobeNewswire)
Oct-13-25 12:22PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +14.08%
09:05AM	PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project (GlobeNewswire)
Oct-10-25 10:02AM	Here's Why You Should Retain PacBio Stock in Your Portfolio for Now (Zacks) -7.19%
Oct-08-25 12:44PM	PacBio Stock Dips Despite Announcing Expanded Partnership With seqWell (Zacks) +7.86%
11:36AM	Why Is PacBio (PACB) Stock Soaring Today (StockStory)
09:05AM	Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity (GlobeNewswire)
Oct-07-25 09:05AM	PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs (GlobeNewswire) -7.89%
Oct-06-25 06:15PM	Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today (Zacks)
Sep-30-25 10:05AM	PacBio Enters Carrier Screening Market With PureTarget Expansion (Zacks)
Sep-22-25 06:15PM	Pacific Biosciences of California (PACB) Rises Higher Than Market: Key Facts (Zacks)
09:05AM	PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes (GlobeNewswire)
Sep-19-25 12:03AM	3 Reasons PACB is Risky and 1 Stock to Buy Instead (StockStory)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gibson James R II	See Remarks	Apr 01 '26	Sale	1.37	88,185	120,813	1,245,663	Apr 03 04:05 PM
JAMES GIBSON	Officer	Apr 01 '26	Proposed Sale	1.37	88,185	120,778		Apr 01 05:17 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '26	Sale	1.51	12,497	18,920	3,581,813	Mar 04 05:55 PM
Van Oene Mark	See Remarks	Mar 03 '26	Sale	1.51	6,504	9,847	2,243,634	Mar 04 05:54 PM
Farmer Michele	See Remarks	Mar 03 '26	Sale	1.51	2,979	4,510	305,948	Mar 04 05:54 PM
MARK D. VAN OENE	Officer	Mar 03 '26	Proposed Sale	1.51	6,504	9,849		Mar 03 04:24 PM
CHRISTIAN HENRY	Officer	Mar 03 '26	Proposed Sale	1.51	12,497	18,924		Mar 03 04:20 PM
Van Oene Mark	See Remarks	Feb 17 '26	Sale	1.58	129,790	204,549	1,797,745	Feb 19 08:33 PM
Van Oene Mark	See Remarks	Feb 18 '26	Sale	1.63	55,107	89,769	1,742,638	Feb 19 08:33 PM
HENRY CHRISTIAN O	See Remarks	Feb 17 '26	Sale	1.58	331,793	522,906	2,814,374	Feb 19 08:31 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '26	Sale	1.63	140,874	229,484	2,673,500	Feb 19 08:31 PM
Farmer Michele	See Remarks	Feb 17 '26	Sale	1.58	35,215	55,499	234,044	Feb 19 08:28 PM
Farmer Michele	See Remarks	Feb 18 '26	Sale	1.63	14,952	24,357	219,092	Feb 19 08:28 PM
MARK VAN OENE	Officer	Feb 17 '26	Proposed Sale	1.58	303,739	478,693		Feb 17 06:27 PM
CHRISTIAN HENRY	Officer	Feb 17 '26	Proposed Sale	1.58	606,312	955,548		Feb 17 06:25 PM
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PACB

Pacific Biosciences of California Inc

Upgrade your Finviz experience